CA2361057A1 — Quinoline derivatives and quinazoline derivatives
Assigned to Kyowa Kirin Co Ltd · Expires 2000-07-27 · 26y expired
What this patent protects
Compounds having an antitumor activity and causing no morphological change i n cells. Compounds of general formula (I), pharmaceutically acceptable salts o f them and solvates thereof, and medicinal compositions containing the same. I n formula (1), X and Z represent each CH or N…
USPTO Abstract
Compounds having an antitumor activity and causing no morphological change i n cells. Compounds of general formula (I), pharmaceutically acceptable salts o f them and solvates thereof, and medicinal compositions containing the same. I n formula (1), X and Z represent each CH or N; R1-3 represent each H, optional ly substituted alkoxy, etc.; R4 represents H; R5-8 represent each H, halogeno, alkyl, alkoxy, alkylthio, nitro or amino, provided that all of R5-8 do not represent H simultaneously; R9 and R10 represent each H, alkyl or alkylcarbonyl; and R11 represents alkyl, alkenyl, alkynyl or aralkyl.</SDOAB >
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.